MDCX Medicus Pharma Ltd. - Common Stock

NASDAQ · Biotechnology · View on SEC EDGAR ↗
$0.26
Price · Aug 19, 2026
Fundamentals as of May 14, 2026
52W Range
$0–$3
1% of range
Analyst Rating
BUY
10 analysts
Price Target
$4
+1599% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—

MDCX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$0.26
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$0 – $3

MDCX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income —
EPS —
Free Cash Flow —
Margins —

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
MDCX
Peer Median

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
MDCX
Peer Median

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
MDCX
Peer Median

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
MDCX
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
MDCX
Peer Median

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
MDCX
Peer Median

MDCX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 10 analysts
  • Strong Buy 2 20.0%
  • Buy 7 70.0%
  • Hold 1 10.0%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

4 analysts · 2026-08-14
Median target $4.00 +1410.6%
Mean target $4.50 +1599.4%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
-0.23%
Period EPS Actual EPS Est Surprise
March 31, 2026 $-0.31 $-0.20 -0.11%
Dec. 31, 2025 $-0.83 $-0.16 -0.67%
Sept. 30, 2025 $-0.65 $-0.30 -0.35%
June 30, 2025 $-0.42 $-0.26 -0.16%
March 31, 2025 $-0.42 $-0.24 -0.18%
Dec. 31, 2024 $-0.18 $-0.30 0.12%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
MDCX — — — — — —
PBM — — — — — —
XENE $3.59B -10.3 — -4612.1% -56.9% —

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 24 filers · $1.1M total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
10 (+3 vs prior Q) 7 (0 vs prior Q) 6 (+1 vs prior Q) 4 (+1 vs prior Q) +259K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
Interchange Capital Partners, LLC $718,376 1,586,871 63.85% Shares
XTX Topco Ltd $108,612 243,362 9.65% Shares
JANE STREET GROUP, LLC $105,107 235,508 9.34% Shares
Sterling Investment Advisors, Ltd. $44,630 100,000 3.97% Shares
COMMONWEALTH EQUITY SERVICES, LLC $23,490 52,643 2.09% Shares
May Hill Capital, LLC $22,593 50,622 2.01% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $14,041 31,462 1.25% Shares
STIFEL FINANCIAL CORP $13,389 30,000 1.19% Shares
JPMORGAN CHASE & CO $12,498 25,622 1.11% Shares
Wilmington Savings Fund Society, FSB $11,435 25,622 1.02% Shares
CITADEL ADVISORS LLC $11,203 25,102 1.00% Shares
Stratos Wealth Partners, LTD. $9,350 20,950 0.83% Shares
LPL Financial LLC $7,816 17,512 0.69% Shares
MARATHON CAPITAL MANAGEMENT $6,918 15,500 0.61% Shares
StoneX Group Inc. $6,365 17,066 0.57% Shares
Foundations Investment Advisors, LLC $4,909 11,000 0.44% Shares
OSAIC HOLDINGS, INC. $3,375 7,500 0.30% Shares
MORGAN STANLEY $446 1,000 0.04% Shares
MERCER GLOBAL ADVISORS INC /ADV $223 500 0.02% Shares
JONES FINANCIAL COMPANIES LLLP $183 400 0.02% Shares
WELLS FARGO & COMPANY/MN $89 200 0.01% Shares
Smithfield Trust Co $11 24,614 0.00% Shares
HAZLETT, BURT & WATSON, INC. $0 425 0.00% Shares
ROYAL BANK OF CANADA $0 1,055 0.00% Shares

Company insiders 14 insiders · 6 officers · 9 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Raza Bokhari Chief Executive Officer June 3, 2026 A — 0 0 $0
Carolyn F. Bonner President and CFO June 3, 2026 A — 0 0 $0
James P. Quinlan Chief Financial Officer Aug. 13, 2025 M 274,147 0 0 $0
Andrew Alasdair Smith Chief Operating Officer June 3, 2026 A — 0 0 $0
Edward J. Brennan Chief Scientific Officer June 3, 2026 A — 0 0 $0
Faisal Mehmud Chief Medical Officer June 3, 2026 A — 0 0 $0
Cathy Mcmorris Rodgers Director June 3, 2026 A — 0 0 $0
Ajay Raju Director June 3, 2026 A — 0 0 $0
Sara R. May Director June 3, 2026 A — 0 0 $0
Larry Kaiser Director June 3, 2026 A — 0 0 $0
Robert J. Ciaruffoli Director June 3, 2026 A — 0 0 $0
Barry Fishman Director June 3, 2026 A — 0 0 $0
William Ashton Director June 3, 2026 A — 0 0 $0
Patrick J Mahaffy Director June 3, 2026 A — 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only